OptimizeRx Corp Quarterly Nonoperating Income (Expense) in USD from Q1 2014 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
Summary
OptimizeRx Corp quarterly/annual Nonoperating Income (Expense) history and growth rate from Q1 2014 to Q3 2024.
  • OptimizeRx Corp Nonoperating Income (Expense) for the quarter ending September 30, 2024 was -$1.38M, a 300% decline year-over-year.
  • OptimizeRx Corp Nonoperating Income (Expense) for the twelve months ending September 30, 2024 was -$5.09M.
  • OptimizeRx Corp annual Nonoperating Income (Expense) for 2023 was $1.24M, a 45.2% increase from 2022.
  • OptimizeRx Corp annual Nonoperating Income (Expense) for 2022 was $852K.
  • OptimizeRx Corp annual Nonoperating Income (Expense) for 2018 was $46.2K, a 78.2% increase from 2017.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Quarterly (USD)
Nonoperating Income (Expense), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 -$5.09M -$1.38M -$2.07M -300% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-14
Q2 2024 -$3.02M -$1.35M -$2.07M -287% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-15
Q1 2024 -$953K -$1.53M -$2.19M -329% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-15
Q4 2023 $1.24M -$836K Oct 1, 2023 Dec 31, 2023 10-K 2024-04-15
Q3 2023 $688K Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-14
Q2 2023 $721K Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-15
Q1 2023 $665K Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-15
Q3 2019 $233K $416K +$395K +1814% Jul 1, 2019 Sep 30, 2019 10-Q 2019-11-05
Q2 2019 -$162K -$73.4K -$80.3K -1162% Apr 1, 2019 Jun 30, 2019 10-Q 2019-08-07
Q1 2019 -$81.4K -$126K -$128K -6329% Jan 1, 2019 Mar 31, 2019 10-Q 2019-05-08
Q4 2018 $46.2K $15.5K +$13.3K +592% Oct 1, 2018 Dec 31, 2018 10-K 2019-03-12
Q3 2018 $32.9K $21.8K +$14.9K +217% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-05
Q2 2018 $18K $6.91K -$2.15K -23.7% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-07
Q1 2018 $20.2K $2.02K -$5.74K -74% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-08
Q4 2017 $25.9K $2.25K -$12.9K -85.2% Oct 1, 2017 Dec 31, 2017 10-K 2019-03-12
Q3 2017 $38.9K $6.87K +$238 +3.59% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-05
Q2 2017 $38.6K $9.06K -$1.52K -14.4% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-07
Q1 2017 $40.2K $7.76K -$2.16K -21.8% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-02
Q4 2016 $42.3K $15.2K +$13.9K +1069% Oct 1, 2016 Dec 31, 2016 10-K 2018-03-08
Q3 2016 $28.4K $6.63K +$6.27K +1703% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-02
Q2 2016 $22.2K $10.6K +$10.3K +3381% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-01
Q1 2016 $11.9K $9.91K +$9.62K +3249% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-03
Q4 2015 $2.27K $1.3K +$996 +329% Oct 1, 2015 Dec 31, 2015 10-K 2017-03-08
Q3 2015 $1.27K $368 +$65.00 +21.5% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-07
Q2 2015 $1.21K $304 +$81.00 +36.3% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-08
Q1 2015 $1.13K $296 +$190 +179% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-09
Q4 2014 $935 $303 Oct 1, 2014 Dec 31, 2014 10-K 2016-03-15
Q3 2014 $303 Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-12
Q2 2014 $223 Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-11
Q1 2014 $106 Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.